Alkermes
ALKS
#2340
Rank
A$11.69 B
Marketcap
A$69.73
Share price
-2.08%
Change (1 day)
70.43%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2026 (TTM): A$0.36 Billion

According to Alkermes's latest financial reports the company's current earnings are A$1.56 Billion. In 2025 the company made an earning of A$0.43 Billion a decrease over its 2024 earnings that were of A$0.66 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.36 B-16.51%
2025 A$0.43 B-34.87%
2024 A$0.66 B-17.97%
2023 A$0.80 B-468.52%
2022 -A$0.22 Billion449.24%
2021 -A$39.98 Million-68.04%
2020 -A$0.13 Billion-52.1%
2019 -A$0.27 Billion64.49%
2018 -A$0.16 Billion-15.04%
2017 -A$0.19 Billion-34.2%
2016 -A$0.29 Billion-5.34%
2015 -A$0.3 Billion35084.97%
2014 -A$0.86 Million
2012 A$10.56 M-117.81%
2011 -A$59.33 Million-12.69%
2010 -A$67.96 Million94.3%
2009 -A$34.98 Million-117.7%
2008 A$0.19 B622.63%
2007 A$27.34 M
2004 -A$0.11 Billion-14.48%
2003 -A$0.13 Billion11.88%
2002 -A$0.12 Billion39.65%
2001 -A$80.94 Million5.73%
2000 -A$76.55 Million-28.91%
1999 -A$0.11 Billion237.28%
1998 -A$31.93 Million100.05%
1997 -A$15.96 Million-37.93%
1996 -A$25.71 Million82.72%
1995 -A$14.07 Million-26.79%
1994 -A$19.22 Million-72.78%
1993 -A$70.61 Million208.07%
1992 -A$22.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.97 B 10,852.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.46 B 6,554.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$15.07 B 4,364.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.90 B 3,128.65%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.66 B 3,945.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.87 B 6,082.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-A$0.31 Billion-189.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.39 Billion-214.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.23 B 857.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel